Tag Archives: XRX

what is stock market

Yesterday, shares of Under Armour (UAA) surged 9.9% as investors cheered its better-than-expected earnings. Baird’s Jonathan Komp and Benjamin Bray, however, note that the Bull-Bear debate around Under Armour is far from over. And remember, this is coming from a pair of bulls.

Jeff Schear/Getty Images for Under Armour

So why do Komp and Bray warn investors not to make too much of yesterday’s big gain? I’ll let them explain:

We are encouraged that UA delivered on Q1 targets (profit upside timing-driven), but view todays ~9% gain as a sign sentiment had moved too negative, and not that current bear arguments are resolved. We think the lowered Q2 bar probably de-risks the near-term outlook, setting up the planned 2H acceleration as a key proof point on whether UA can successfully shift its product/positioning. We are staying the course, and will seek opportunities (hopefully during 2H) to raise our conviction level.

what is stock market: Ballard Power Systems, Inc.(BLDP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Jim Robertson]

    With that in mind, I would add any stocks or sectors that benefit directly or indirectly from government subsidies because they are in cool or chosensectors that progressive liberal types worshipe.g. so called green or renewable energy or green technology plays like small capsBallard Power Systems Inc (NASDAQ: BLDP),FuelCell Energy Inc (NASDAQ: FCEL) and Plug Power Inc (NASDAQ: PLUG) along with solarinstallers Vivint Solar Inc (NYSE: VSLR) and Sunrun Inc (NASDAQ: RUN). Then there are thebigger and more globalsolar energy solutions stocks like First Solar, Inc (NASDAQ: FSLR) and SunPower Corporation (NASDAQ: SPWR) that will no doubt be the focus of any energy policy or global warming policy coming out of Washington.

  • [By Lisa Levin]

    Friday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Peter Graham]

    A long term performance chart shows shares of Plug Power plus alternative energy or fuel cell stock peers like Ballard Power Systems Inc (NASDAQ: BLDP), FuelCell Energy Inc (NASDAQ: FCEL) and Hydrogenics Corporation (NASDAQ: HYGS) all peaking in 2014 before collapsing with shares leveling off or perhaps finally to recover a bit:

what is stock market: Xerox Corporation(XRX)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Xerox Corp. (NYSE: XRX) which rose 3.8% to $30.56. The stocks 52-week range is $22.90 to $30.76. Volume was 3.8 million compared to its average volume of 2.3 million.

  • [By Paul Ausick]

    Xerox Corp. (NYSE: XRX) dropped about 23% on Tuesday to post a new 52-week low of $6.46 after closing at $8.73 on Friday. The dip was the result of the company’s completed separation into two firms this morning. After the early drop shares had gained around 17% by late afternoon, probably on the strength of a cash payment of $1.8 billion.

what is stock market: Old National Bancorp Capital Trust I(ONB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

  • [By kiplinger]

     Old National Bancorp (ONB) is a 181-year-old financial institution with 195 branches, mainly in the Midwest. The stock, which is still down by about one-third from its prerecession high, trades at just 13 times projected 2016 earnings and yields an attractive 3.4%. If interest rates ever rise, the bank should benefit from a widening spread between its cost of funds and the interest rates borrowers pay.

    It’s a favorite of David Dreman, author of the classic 1980 book Contrarian Investment Strategy. His philosophy: “We believe that the markets are not perfectly efficient.” Some stocks, in other words, are judged by the market to be cheaper than their actual worth.

what is stock market: Virtus Investment Partners Inc.(VRTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Virtus Investment Partners Inc (NASDAQ: VRTS) got a boost, shooting up 19 percent to $111.05 following Q3 results. Virtus Investment posted Q3 earnings of $1.64 per share on revenue of $82.3 million.

what is stock market: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 30 percent to $20.08 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 14 percent to $20.96. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Todd Campbell]

    Portola Pharmaceuticals’ (NASDAQ:PTLA)could have two commercial-stage drugs on the market next year, but turning them into top-sellers will require a lot of money. Is Portola Pharmaceuticals’ balance sheet flush enough with cash to get its drugs across the finish line?

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 23 percent to $21.92 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 16 percent to $20.43. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares were also up, gaining 46 percent to $55.68 after the company disclosed that the FDA has approved Bevyxxa, a blood-thinner for acutely ill patients not undergoing surgery. BevyxXa is the first oral drug of its kind to be approved to help prevent deep vein thrombosis and pulmonary embolisms..